Last reviewed · How we verify

VN

Biomedical Advanced Research and Development Authority · FDA-approved active Biologic

Venezuelan equine encephalitis virus (VEEV) vaccine is a live, attenuated vaccine that stimulates an immune response against VEEV.

Venezuelan equine encephalitis virus (VEEV) vaccine is a live, attenuated vaccine that stimulates an immune response against VEEV. Used for Prevention of Venezuelan equine encephalitis.

At a glance

Generic nameVN
Also known asA/Vietnam/1203/2004 vaccine antigen strain H5N1
SponsorBiomedical Advanced Research and Development Authority
Drug classlive, attenuated vaccine
ModalityBiologic
Therapeutic areaInfectious Disease
PhaseFDA-approved

Mechanism of action

The vaccine works by introducing a weakened form of the VEEV virus into the body, which triggers an immune response and helps the body develop antibodies to fight the virus. This immune response provides protection against future infections with VEEV.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: